Anti-inflammatory

This page covers all Anti-inflammatory drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Unknown, IL-17, COX-2.

Targets

Unknown · IL-17 · COX-2 · IL-6 receptor

Phase 3 pipeline (3)

• Duration of Treatment: Z-Phase, 2 years. · Organon and Co · Rheumatology
  Z-Phase is a medication that targets the body's natural processes to reduce inflammation and slow disease progression.
• OPC-1085EL ophthalmic solution · Otsuka Pharmaceutical Co., Ltd. · Ophthalmology
  OPC-1085EL ophthalmic solution is an anti-inflammatory agent.
• Nephrosolid tablets · A. Vogel AG · Nephrology
  Nephrosolid tablets work by reducing inflammation in the kidneys.

Phase 2 pipeline (5)

• Anti-IL17 · Prof. Dr. Stephan Weidinger · Immunology
  IL-17 inhibitor
• ACP injections · Salus Ltd. · Orthopedics
  ACP injections work by targeting a specific molecular pathway to reduce inflammation and promote healing.
• DE-117 Ophthalmic Solution BID · Santen Inc. · Ophthalmology
  DE-117 Ophthalmic Solution BID is an anti-inflammatory agent.
• BL1107 High dose · Bausch & Lomb Incorporated · Ophthalmology
  BL1107 High dose is an anti-inflammatory agent.
• Euphorbia tablets · Panacea Biotec Ltd · Dermatology
  Euphorbia tablets are believed to have anti-inflammatory properties.

Phase 1 pipeline (1)

• Anti-IL6 · Marie Hudson, MD · Immunology
  IL-6 receptor antagonist